Androscoggin Cardiology Associates is a multi-physician cardiology practice with a dedicated research department of 11 fulltime employees. Under the direction of Dr. Weiss, our site has been one of the leading cardiology practices in Central Maine for over 20 years. We have conducted hundreds of clinical research trials, Phases II- IV, with many prominent leaders of the pharmaceutical industry as well as the National Institute of Health and National Heart, Lung and Blood Institute.
We are committed to delivering the highest quality of compassionate care to our patients and personalized service to our professional colleagues. We aspire to be the preeminent full service cardiology group serving northern New England and to improve the cardiovascular health of our community today with the hopes that our participation in research will further advance treatment for tomorrow.
Androscoggin Cardiology Associates has been conducting research for over 20 years. We continue to specialize and conduct research in the following areas:
- Acute Coronary Syndromes
- Atrial Fibrillation
- Acute Myocardial Infarction
- Coronary Artery Disease
- Congestive Heart Failure
- Diabetes
- Hypertension
- Hypercholesterolemia
- Familial Hypercholesterolemia
- Dyslipidemia
- Metabolic Syndrome
- Myocardial Infarction
- Nuclear Imaging Agents
- Obesity
- Osteoarthritis
- Peripheral Arterial/Vascular Disease
We have worked with many sponsors and their CROs over the last 2 decades. Sponsors and CROS of clinical trials conducted at Androscoggin Cardiology Associates include but are not limited to the following:
- Abbott Labs
- Alteon, Inc.
- Angiogenix
- AstraZeneca, LP
- Atherogenics
- Avant Immunotherapeutics, Inc.
- Bayer
- Bertek Pharmaceuticals
- Biovail
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Bristol-Myers Squibb Medical Imaging
- Cardiome
- Eli Lilly
- Endo Pharmaceuticals
- Esperion
- Forest Labs
- GlaxoSmithKline
- Guidant
- Guilford Pharmaceuticals
- Hoffman-La Roche
- King Pharmaceuticals
- Kos Pharmaceuticals
- Myogen
- Novartis
- Otsuka Pharmaceuticals
- Pfizer, Inc.
- Proctor & Gamble, Inc.
- Sankyo
- Sanofi-Synthelabo
- Schering-Plough Research Institute
- Takeda Pharmaceuticals
- Valentis, Inc.
- Vasogen
- Wyeth
CROs
- Cardiovascular Clinical Studies, LLC
- Cleveland Clinic Coordinating Center
- Covance
- Duke Clinical Research Institute
- ICON
- Integrium
- MDS Pharma Services
- Medifacts International
- Medpace
- Omnicare
- Paragon Biomedical
- Parexel
- PPD
- Quintiles
- The Covalent Group
- TIMI
Our medical expertise is derived from the highly experienced and respected leaders of our site:
- Robert J. Weiss, MD, FACC, FACP
- David N. Abisalih, MD, FACC
- Dervilla M. McCann, MD, FACC
- Deborah Freeman, RNC, BS, FNP
With a full-time staff of 30, Androscoggin Cardiology Associates employs a management team, support staff for our physicians and nurse practitioners, 6 research coordinators, a regulatory documents specialist and 3 research assistants. Our research staff comprises 11 of these employees who are responsible for research on a full-time basis.
Our patient population ranges from adult to geriatric men and women with a broad range of cardiac indications and levels of disease. Primarily Caucasian, our site does have a small population of other ethnicities and races. Particular to our site is the large population of French-Canadian descent that resides within our area of the State of Maine.
Cardiology/Vascular Diseases
Androscoggin Cardiology Associates is an outpatient based office located within 2 miles of both Central Maine Medical Center and St. Mary's Regional Medical Center. We have exercise treadmill testing, an echocardiogram and a nuclear department on-site with easy access to any other necessary testing. We are a full-service cardiology practice with physicians board certified in internal medicine as well as cardiology.
Robert J. Weiss, MD
Director of Research
Androscoggin Cardiology Associates
2 Great Falls Plaza
Auburn, ME 04210
USA
207-782-9835
207-783-2795 (fax)
rweiss@exploremaine.com